← Open Payments lookup

SHAKUNTALA JAIN: Open Payments

NPI 1629157771 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$769 in 33 payments from 11 companies in 2025. Trend: 2023 $186 · 2024 $440 · 2025 $769

Food & beverage: $769
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$164
Neurocrine BioSciences, Inc.4$123
Otsuka America Pharmaceutical, Inc.3$78
Alkermes, Inc.3$76
Vanda Pharmaceuticals Inc.2$74
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$64
ABBVIE INC.3$62
E.R. Squibb & Sons, L.L.C.3$53
Janssen Pharmaceuticals, Inc2$46
Luye Pharma (USA) Ltd.1$14

Products named: INGREZZA, AUSTEDO XR, UZEDY, FANAPT, REXULTI, CAPLYTA, VRAYLAR, COBENFY.

Industry payments across AZ — which companies pay providers there.